Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of AgeCongenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Lymphatic Abnormalities, lymphatic malformation, lymphatic system disorderRecruitingPhase 22026-08-24NCT05871970

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Protara Therapeutics4

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Arkansas Children's Hospital/UAMSLittle RockUnited States1
Children's Hospital of AlabamaBirminghamUnited States2
Children's Hospital of ColoradoAuroraUnited States1
Children's Hospital of Philadelphia: Comprehensive Vascular Anomalies ProgramPhiladelphiaUnited States1
Children's Hospital of The King's DaughtersNorfolkUnited States87
Children's National Medical Center: Children's Research InstituteWashington D.C.United States3
Cincinnati Children's Hospital Medical CenterCincinnatiUnited States405
Mount Sinai HospitalNew YorkUnited States225
Nemours Children's Clinic - JacksonvilleJacksonvilleUnited States1
Oregon Health & Science UniversityPortlandUnited States261
Vanderbilt University Medical CenterNashvilleUnited States427